瘤胆固醇合成,静止剂使用和致命的前列腺癌
Sinead Flanagan1, Rosina T Lis2, Ying Huang3
1Harvard T.H. Chan School of Public Health, Boston, MA, United States.
Molecular cancer research : MCR
|August 5, 2025
概括
在前列腺瘤中,高表达3 - - 3 - 甲基 - 谷氨基 - 共酶A减酶 (HMGCR) 与致命癌症的风险增加有关. 这表明HMGCR可能是前列腺癌新疗法的目标.
科学领域:
- 在瘤学瘤学.
- 生物化学 生物化学
- 分子生物学分子生物学
背景情况:
- 前列腺瘤细胞合成新的胆固醇.
- 达丁类药物治疗的目标是3-基-3-甲基-氨酸-共酶A减少酶 (HMGCR),这是胆固醇合成中的关键酶.
- HMGCR表达在前列腺癌进展和对他类药物的反应中的作用尚未完全理解.
研究的目的:
- 研究前列腺瘤中HMGCR表达与癌症致死率之间的关联.
- 探索HMGCR表达,PTEN损失和瘤攻击性之间的关系.
- 为了评估他类药物对前列腺癌细胞与改变的HMGCR水平的体外效应.
主要方法:
- 对1098名被诊断为原发性前列腺癌的男性进行前性队列研究.
- 在瘤组织中分析HMGCR蛋白表达.
- 对致命事件 (转移,癌症相关死亡) 的随访时间长达32年.
- 使用LNCaP人类前列腺癌细胞系的体外实验.
主要成果:
- 16%的瘤显示出强烈的HMGCR染色;31%没有染色.
- 强烈的HMGCR表达与致命前列腺癌的风险增加2.2倍有关.
- 在 PTEN 损失的瘤中,HMGCR 表达更高.
- 阿托瓦斯塔丁降低了前列腺癌细胞的活力,实验性降低了HMGCR.
结论:
- 在前列腺瘤中高HMGCR表达与侵略性特征和致死性风险增加相关.
- HMGCR表达与PTEN损失有关,这表明胆固醇合成和瘤抑制途径之间存在联系.
- 这些发现凸显了HMGCR作为侵袭性前列腺癌的潜在治疗点.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
873
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
873
Cholesterol: Significance and Regulation
687
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
687
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K


